8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: April 20, 2005

Commission file number: 0-16946

LabOne, Inc.

10101 Renner Blvd.

Lenexa, Kansas 66219

(913) 888-1770

Incorporated in Missouri

I.R.S. Employer Identification Number: 43-1039532

Item 1.01 Entry into a Material Definitive Agreement

On April 20, 2005, LabOne, Inc. and American Stock Transfer and Trust Company amended the parties' February 11, 2000 Rights Agreement, as previously amended on August 31, 2001 ("Rights Agreement").

The Rights Agreement grants Company shareholders the right to purchase Company common stock for one-half of the stock's market price if a person becomes the beneficial owner of fifteen percent (15%) or more of the Company's outstanding common stock ("Acquiring Person"), subject to the terms and conditions of the Rights Agreement. Prior to this amendment, the Rights Agreement exempted parties affiliated with Welsh, Carson, Anderson & Stowe and family members of W. T. Grant from the definition of "Acquiring Person," even if such parties acquired fifteen percent (15%) or more of the Company's common stock.

This amendment removes the exemptions pertaining to Welsh, Carson, Anderson & Stowe and the family members of W.T. Grant from the Rights Agreement's definition of "Acquiring Person." Thus, subject to the terms and conditions of the Rights Agreement, such parties' acquisition of fifteen percent (15%) or more of the Company's common stock would trigger the rights specified in the Rights Agreement on the same basis as other non-exempt acquirers.

This summary is qualified in its entirety by the text of the amendment to the Rights Agreement, which is attached hereto as Exhibit 4.1.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits

4.1 Amendment No. 2 to the Rights Agreement

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

LabOne, Inc.

Date:  April 25, 2005 By /s/ John W. McCarty
John W. McCarty
Executive V.P. and Chief Financial Officer

EX-4

AMENDMENT NO. 2 TO THE RIGHTS AGREEMENT

THIS AMENDMENT NO. 2 TO THE RIGHTS AGREEMENT, dated as of April 20, 2005, is made between LabOne, Inc., a Missouri corporation (the "Company"), and American Stock Transfer & Trust Company (the "Rights Agent").

W I T N E S S E T H

WHEREAS, on February 11, 2000, the Company and the Rights Agent entered into a Rights Agreement (the "Rights Agreement") to provide certain Rights to holders of Common Stock; and

WHEREAS, on August 31, 2001, the Company and the Rights Agent entered into Amendment No. 1 to the Rights Agreement; and

WHEREAS, the parties hereto desire to amend the Rights Agreement as previously amended;

NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:

1. Subsection (a) of Section 1 is hereby deleted in its entirety, and the following new subsection (a) is hereby inserted in lieu thereof:

(a) "Acquiring Person" shall mean any Person who or which, together with all Affiliates and Associates of such Person, without the Prior Written Approval of the Company granted after the date hereof, shall be the Beneficial Owner of 15% or more of the shares of Common Stock then outstanding, other than as a result of a Qualifying Offer, whether or not such Person together with all Affiliates and Associates of such Person continues to be the Beneficial Owner of 15% or more of such shares. Notwithstanding the foregoing,

(i) the term "Acquiring Person" shall not include any Exempt Person (as hereinafter defined),

(ii) a Person shall not become an Acquiring Person solely as a result of a reduction in the number of shares of Common Stock outstanding due to the repurchase of shares of Common Stock by the Company, unless and until such Person (together with all Affiliates and Associates of such Person) shall purchase or otherwise become the Beneficial Owner of additional shares of Common Stock, other than pursuant to a Qualifying Offer or with the Prior Written Approval of the Company,

(iii) notwithstanding any other provision hereof to the contrary, a Person shall not be deemed to be an Acquiring Person if, within ten Business Days after the Board of Directors is given written notice that such Person has become an Acquiring Person, the Board of Directors determines in good faith that such Person who would otherwise be an "Acquiring Person" has become such inadvertently and the Board of Directors provides such Person a period not to exceed thirty days to divest a sufficient number of securities so that such Person would no longer be an Acquiring Person, as defined in the foregoing provisions of this paragraph (a), and such Person has so divested prior to the end of such period.

Notwithstanding anything in this Agreement to the contrary, the term "then outstanding," when used with reference to a Person's beneficial ownership of securities of the Company, shall mean the number of such securities then issued and outstanding together with the number of such securities not then actually issued and outstanding which such Person would be deemed to beneficially own hereunder.

2. Subsection (b) of Section 1 is hereby amended by deleting the following from the end of subsection (b):

Notwithstanding the foregoing, (i) no Affiliate or Associate of any of the WCAS Parties that is not a Controlled Entity shall be deemed to be the Beneficial Owner of shares of Common Stock beneficially owned by the WCAS Parties solely by reason of such Person being an Affiliate or Associate of any of the WCAS Parties and (ii) none of the Grant Family Members, on the one hand, and WCAS Parties, on the other hand, shall be deemed to beneficially own the shares of Common Stock beneficially owned by the other as a result of (A) the execution, delivery and performance of the Voting Agreement dated August 31, 2001 between certain WCAS Parties and certain Grant Family Members or (B) compliance by the Company and any of the WCAS Parties with Section 6.02 of the Securities Purchase Agreement.

3. Subsection (u) of Section 1 is hereby deleted in its entirety, and the following new subsection (u) is hereby inserted in lieu thereof:

(u) Intentionally Omitted.

4. Subsection (y) of Section 1 is hereby deleted in its entirety, and the following new subsection (y) is hereby inserted in lieu thereof:

(y) "Prior Written Approval" shall mean the prior express written consent of the Company to any Person becoming an Acquiring Person, executed on behalf of the Company by a duly authorized officer of the Company following express approval by action of the Board of Directors, provided that all conditions precedent and subsequent established by the Board of Directors (and not waived by the Board of Directors prior to violation of any such condition) in connection with such approval shall be satisfied.

5. Section 1 is hereby amended to delete subsections (qq), (rr) and (ss).

6. Section 27 is hereby deleted in its entirety, and the following new Section 27 is hereby inserted in lieu thereof:

At any time and from time to time prior to the close of business on the tenth Business Day after the Stock Acquisition Date, the Board of Directors, upon vote of a majority of the Board of Directors then in office, may in its sole and absolute discretion amend or supplement this Agreement without the approval of any holders of Rights. At any time and from time to time after the close of business on the tenth Business Day after the Stock Acquisition Date, the Board of Directors, upon vote of a majority of the Board of Directors then in office, may supplement or amend this Agreement without the approval of any holders of the Rights, provided that no such supplement or amendment adversely affects the interests of the holders of Rights as such (other than an Acquiring Person or an Affiliate or Associate of an Acquiring Person). Upon the delivery of a certificate from an appropriate officer of the Company which states that the proposed supplement or amendment is in compliance with the terms of this Section 2 7, the Rights Agent shall execute such supplement or amendment; provided, however, that the Rights Agent may, but shall not be obligated to, enter into any such supplement or amendment which adversely affects the Rights Agent's own rights, duties or immunities under this Agreement.

IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 2 to the Rights Agreement to be duly executed as of the day and year first above written.

LABONE, INC.,

by /s/ W. Thomas Grant II
Name: W. Thomas Grant
Title: Chairman of the Board, President
and Chief Executive Officer

American Stock Transfer & Trust Company

by /s/ Herbert J. Lemmer
Name: Herbert J. Lemmer
Title: Vice President

-----END PRIVACY-ENHANCED MESSAGE-----